# Genetic Technologies Ltd (GENE)

Source: https://www.quantisnow.com/company/GENE
Generated: 2026-11-15T17:03:04.961Z

- Ticker: GENE
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Biological Products (No Diagnostic Substances)
- Website: gtglabs.com

## About

Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. It also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, the company offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include cardiovascular, type 2 diabetes, prostate cancer, and melanoma. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. The company has research and collaboration agreements with the University of Melbourne, Translational Genomics Research Institute, Memorial Sloan Kettering New York Cambridge University, the Ohio State University, and Shivom. Genetic Technologies Limited was incorporated in 1987 and is headquartered in Fitzroy, Australia.

## Latest GENE news and filings

- 2024-12-12 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5810472)
- 2024-12-02 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5795269)
- 2024-11-20 13:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5784362)
- 2024-10-31 12:11 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5745572)
- 2024-10-28 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5739395)
- 2024-10-11 13:00 UTC [Earnings Date] [BioVie and Genetic Technologies Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV](https://www.quantisnow.com/insight/biovie-and-genetic-technologies-interviews-to-air-on-the-redchip-5723144)
- 2024-10-01 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5709514)
- 2024-10-01 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5709509)
- 2024-09-30 12:09 UTC [SEC Form 20-F filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-20-f-filed-by-genetic-technologies-ltd-5707924)
- 2024-09-23 12:30 UTC [Conference Announcement] [Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on October 2](https://www.quantisnow.com/insight/join-genetic-technologys-exclusive-live-investor-webinar-and-qa-session-5701697)
- 2024-09-11 13:47 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5690184)
- 2024-09-11 12:15 UTC [Leadership Update] [Genetic Technologies Invited to Join Prestigious "CancerIQ" Online Platform - Provides Access to 45 Healthcare Systems and 250 Clinics](https://www.quantisnow.com/insight/genetic-technologies-invited-to-join-prestigious-canceriq-online-platform---5690028)
- 2024-08-28 12:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5674364)
- 2024-08-15 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5660707)
- 2024-08-15 12:00 UTC [Genetic Technologies Announces Global Launch of geneType™ on Wholly Owned EasyDNA platform](https://www.quantisnow.com/insight/genetic-technologies-announces-global-launch-of-genetype-on-wholly-owned-5660651)
- 2024-08-09 12:00 UTC [Conference Announcement] [Join Genetic Technology's Exclusive Live Investor Webinar and Q&A Session on August 15](https://www.quantisnow.com/insight/join-genetic-technologys-exclusive-live-investor-webinar-and-qa-session-5652116)
- 2024-07-31 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5634643)
- 2024-07-26 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5629372)
- 2024-07-26 12:00 UTC [Genetic Technologies Strategic Restructure Driving USA Sales Growth](https://www.quantisnow.com/insight/genetic-technologies-strategic-restructure-driving-usa-sales-growth-5629345)
- 2024-07-23 20:30 UTC [Market Insight] [Cannabis Stock Gainers And Losers From July 23, 2024](https://www.quantisnow.com/insight/cannabis-stock-gainers-and-losers-from-july-23-2024-5622935)
- 2024-07-22 20:30 UTC [Market Insight] [Marijuana Stock Movers For July 22, 2024](https://www.quantisnow.com/insight/marijuana-stock-movers-for-july-22-2024-5620392)
- 2024-07-16 12:02 UTC [Market Chatter] [Genetic Technologies Appoints Mark Ziirsen As Chief Financial Officer](https://www.quantisnow.com/insight/genetic-technologies-appoints-mark-ziirsen-as-chief-financial-officer-5609640)
- 2024-07-16 12:00 UTC [Leadership Update] [Genetic Technologies Announces Appointment of Chief Financial Officer & Company Secretary](https://www.quantisnow.com/insight/genetic-technologies-announces-appointment-of-chief-financial-officer-company-secretary-5609584)
- 2024-07-15 20:30 UTC [Market Insight] [Cannabis Stock Gainers And Losers From July 15, 2024](https://www.quantisnow.com/insight/cannabis-stock-gainers-and-losers-from-july-15-2024-5608640)
- 2024-07-12 20:30 UTC [Market Insight] [Cannabis Stock Movers For July 12, 2024](https://www.quantisnow.com/insight/cannabis-stock-movers-for-july-12-2024-5606526)
- 2024-07-10 20:30 UTC [Market Insight] [Bearish Sentiment Across The Cannabis Space - Check Full Movers For July 10, 2024](https://www.quantisnow.com/insight/bearish-sentiment-across-the-cannabis-space---check-full-movers-5602389)
- 2024-07-09 20:30 UTC [Market Insight] [Cannabis Stock Gainers And Losers From July 9, 2024](https://www.quantisnow.com/insight/cannabis-stock-gainers-and-losers-from-july-9-2024-5600072)
- 2024-07-09 12:13 UTC [Market Chatter] [GeneType Announces The Introduction Of Suite Of Genetic Risk Assessment Tests To Canada And New Zealand](https://www.quantisnow.com/insight/genetype-announces-the-introduction-of-suite-of-genetic-risk-assessment-5598797)
- 2024-07-09 12:00 UTC [GeneType to Enter Canadian and New Zealand Markets](https://www.quantisnow.com/insight/genetype-to-enter-canadian-and-new-zealand-markets-5598645)
- 2024-07-02 20:30 UTC [Market Insight] [Marijuana Stock Movers For July 2, 2024](https://www.quantisnow.com/insight/marijuana-stock-movers-for-july-2-2024-5590523)
- 2024-06-28 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5582646)
- 2024-06-28 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5582642)
- 2024-06-27 20:30 UTC [Market Insight] [Cannabis Stock Gainers And Losers From June 27, 2024](https://www.quantisnow.com/insight/cannabis-stock-gainers-and-losers-from-june-27-2024-5581591)
- 2024-06-25 20:30 UTC [Market Insight] [Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 25, 2024](https://www.quantisnow.com/insight/bearish-sentiment-across-the-cannabis-space---check-full-movers-5576635)
- 2024-06-25 12:00 UTC [GeneType Identifies 79.5% of People Tested are at Risk of Serious Disease](https://www.quantisnow.com/insight/genetype-identifies-795-of-people-tested-are-at-risk-of-5575167)
- 2024-06-25 10:31 UTC [Market Chatter] [Genetic Technologies Reported Monday, geneType Identifies 79.5% Of People Tested In U.S., Australia Are At Risk Of Serious Disease](https://www.quantisnow.com/insight/genetic-technologies-reported-monday-genetype-identifies-795-of-people-tested-5574890)
- 2024-06-21 12:00 UTC [SEC Form 6-K] [SEC Form 6-K filed by Genetic Technologies Ltd](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-genetic-technologies-ltd-5570053)
- 2024-06-21 12:00 UTC [Conference Announcement] [Join Genetic Technologies' Exclusive Live Investor Webinar and Q&A Session on June 27](https://www.quantisnow.com/insight/join-genetic-technologies-exclusive-live-investor-webinar-and-qa-session-5570022)
- 2024-06-18 12:00 UTC [Market Chatter] [Genetic Technologies Expands Operations In North America](https://www.quantisnow.com/insight/genetic-technologies-expands-operations-in-north-america-5563746)
- 2024-06-18 12:00 UTC [Genetic Technologies Expands Operational Capacity in North America](https://www.quantisnow.com/insight/genetic-technologies-expands-operational-capacity-in-north-america-5563684)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/GENE
- Earnings history: https://www.quantisnow.com/earnings/GENE
- Dividend history: https://www.quantisnow.com/dividends/GENE
- Insider transactions: https://www.quantisnow.com/insiders/GENE
- Options chain: https://www.quantisnow.com/options/GENE
- SEC 8-K filings only: https://www.quantisnow.com/company/GENE/8-k
- RSS and alerts for GENE: https://www.quantisnow.com/docs/rss-feeds.md